M Sideri
Overview
Explore the profile of M Sideri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
403
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bottari F, Igidbashian S, Boveri S, Tricca A, Gulmini C, Sesia M, et al.
J Clin Pathol
. 2016 Sep;
70(4):327-330.
PMID: 27672216
Aims: Mortality for cervical cancer varies between the different regions of the world, with high rates in low-income countries where screening programmes are not present and organised. However, increasing screening...
2.
Sideri M, Spinaci L, Schettino F, Mezzetti M, Robertson C, Spolti N, et al.
J Low Genit Tract Dis
. 2015 May;
3(1):45.
PMID: 25950322
No abstract available.
3.
Sideri M, Spinaci L, Schettino F, Origoni M
J Low Genit Tract Dis
. 2015 May;
3(1):35.
PMID: 25950301
No abstract available.
4.
Bottari F, Sideri M, Gulmini C, Igidbashian S, Tricca A, Casadio C, et al.
J Clin Microbiol
. 2015 Apr;
53(7):2109-14.
PMID: 25903574
Analytical and clinical performance validation is essential before introduction of a new human papillomavirus (HPV) assay into clinical practice. This study compares the new BD Onclarity HPV assay, which detects...
5.
Giorgi Rossi P, Fortunato C, Barbarino P, Boveri S, Caroli S, Del Mistro A, et al.
Br J Cancer
. 2015 Jan;
112(4):667-75.
PMID: 25633037
Background: We performed a multicentre randomised controlled trial to evaluate the effect on participation in organised screening programmes of a self-sampling device mailed home or picked up at a pharmacy...
6.
DeCensi A, Bonanni B, Maisonneuve P, Serrano D, Omodei U, Varricchio C, et al.
Ann Oncol
. 2013 Jul;
24(11):2753-60.
PMID: 23864098
Background: Postmenopausal hormone replacement therapy (HRT) relieves menopausal symptoms and may decrease mortality in recently postmenopausal women, but increases breast cancer risk. Low-dose tamoxifen has shown retained activity in phase-II...
7.
Sandri M, Bottari F, Franchi D, Boveri S, Candiani M, Ronzoni S, et al.
Gynecol Oncol
. 2012 Dec;
128(2):233-8.
PMID: 23200911
Objective: The quality of first surgery is one of the most important prognostic factors in ovarian cancer patients. Pre-surgical distinction of benign and malignant pelvic mass plays a critical role...
8.
Origoni M, Carminati G, Sideri M, Clementi M, Rolla S, Candiani M
Eur J Gynaecol Oncol
. 2012 Aug;
33(3):261-4.
PMID: 22873095
The correlation between high-risk HPV-DNA viral load, expressed as relative light units (RLU) values obtained from the Hybrid Capture 2 (HC2) test, and the prevalence of CIN2/CIN3 was investigated and...
9.
Origoni M, Cristoforoni P, Costa S, Mariani L, Scirpa P, Lorincz A, et al.
Ecancermedicalscience
. 2012 Jul;
6:258.
PMID: 22778786
The large amount of literature published over the last two decades on human papillomavirus (HPV)-DNA testing has definitely demonstrated the association between high-risk viral genotypes (hrHPV) and cervical cancer. Moreover,...
10.
Origoni M, Carminati G, Rolla S, Clementi M, Sideri M, Sandri M, et al.
Eur J Clin Microbiol Infect Dis
. 2012 Mar;
31(9):2401-6.
PMID: 22382821
Human papillomavirus (HPV) testing is more sensitive and has higher negative predictive value (NPV) than the Pap test for the detection of cervical intraepithelial neoplasia (CIN) in patients with atypical...